Description
Fluvoxamine Maleate Film-Coated Tablets (50 mg / 100 mg)
Healthy Inc is a specialized global supplier and exporter of advanced psychiatry, neuro-pharmacology, and targeted behavioral therapeutics. We provide ultra-high-purity, kinetically synchronized Fluvoxamine Maleate Film-Coated Tablets (50 mg / 100 mg), manufactured in WHO–GMP certified, high-precision oral solid dosage facilities. This “Sigma-1 Agonist & Selective Serotonin Reuptake Inhibitor (SSRI)” is a massive-volume, highly critical export to psychiatric hospitals, behavioral health networks, severe anxiety clinics, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, first-line intervention for severe Obsessive-Compulsive Disorder (OCD) and Social Anxiety Disorder (SAD).
Product Overview
This highly advanced formulation operates as a profound neurochemical regulator. Rather than acting as a simple mood elevator, it specifically targets the rigid, repeating neurological “loops” that trap patients in agonizing obsessive thoughts and compulsive behaviors.
The “OCD Anchor & Sigma-1 Receptor” Specialist:
- Mechanism 1 (The Serotonin Transporter Blockade): Like other SSRIs, Fluvoxamine violently binds to the Serotonin Transporter (SERT) on the presynaptic neuron. By blocking this cellular vacuum cleaner, it forces massive amounts of Serotonin to remain in the synaptic cleft. Over weeks of therapy, this sustained serotonin bath forces the brain’s receptors to down-regulate and physically rewire the neural pathways driving severe anxiety.
- Mechanism 2 (The Sigma-1 Agonism Paradox): This is Fluvoxamine’s absolute superpower. Unlike almost every other SSRI, Fluvoxamine has a massive affinity for the Sigma-1 ($\sigma_1$) receptor located on the endoplasmic reticulum inside the cell. Agonizing this receptor triggers profound neuroprotection, massive reductions in neuro-inflammation, and accelerated cellular repair. This unique mechanism is heavily theorized to be the reason Fluvoxamine is vastly superior to other SSRIs for treating the rigid neurological loops of OCD.
- Mechanism 3 (The Melatonin Preservation): Fluvoxamine heavily inhibits the breakdown of endogenous melatonin. Consequently, it is highly sedating and restorative for sleep architecture, making it the perfect nighttime intervention for psychiatric patients suffering from severe insomnia driven by racing thoughts.
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers, Psychiatric Distributors, and Hospital Procurement Boards.
| HS Code | 3004.90.99 (Medicaments containing other active substances – Psychiatry/Antidepressants) |
| CAS Number | 61718-82-9 (Fluvoxamine Maleate) |
| Dosage Form | Film-Coated Tablet (Immediate Gastric Release – Scored for Titration) |
| Packaging | High-Density Alu-PVC or Alu-Alu Blisters. Protects the formulation from environmental humidity across Zone IVb tropical climates, preventing premature degradation of the psychiatric payload. |
| Storage | Store strictly below 30°C in a dry place. Protect heavily from Moisture and Light. |
Manufacturing Authority
Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.
- Titration Engineering & Content Uniformity (CRITICAL COMPLIANCE): The clinical success of Fluvoxamine relies entirely on exact dose escalation. If a patient receives an unevenly blended tablet, it can trigger severe serotonin spikes, massive nausea, or panic attacks, causing them to abandon the life-saving therapy. Our psychiatric suites utilize high-shear wet granulation and intensive HPLC batch-testing to guarantee absolute Content Uniformity across every scored 50mg and 100mg tablet, providing psychiatrists with a structurally flawless clinical tool.
Therapeutic Indications (Human Use)
Indicated for the targeted, highly specialized management of severe anxiety and behavioral loops:
- Obsessive-Compulsive Disorder (OCD): The globally mandated, first-line pharmacological treatment for severe obsessions and compulsions in adults and pediatric patients (8 years and older).
- Social Anxiety Disorder (SAD): Treatment of extreme, debilitating social phobias.
- Major Depressive Disorder (Off-Label / Regional): Utilized heavily for depressive episodes characterized by severe, racing anxious thoughts and insomnia.
Dosage & Administration
Recommended Dosage (Strictly as per Psychiatrist Guidelines):
- The Nighttime Protocol: Fluvoxamine is highly sedating. The initial dose (usually 50 mg) MUST be given at bedtime to minimize daytime somnolence and sleep through the initial gastrointestinal nausea.
- The OCD Escalation: Doses are typically increased by 50 mg every 4 to 7 days. Maximum therapeutic benefit for OCD often requires aggressive dosing of 200 mg to 300 mg daily (doses over 100 mg should be divided twice daily).
- Delayed Onset: Patients must be explicitly counseled that anti-obsessional effects take 4 to 10 weeks of continuous daily use to fully manifest.
Safety Warnings (CRITICAL Regulatory & Clinical Data):
- BLACK BOX WARNING (Suicidal Ideation): Like all antidepressants, Fluvoxamine massively increases the risk of suicidal thinking and behavior in children, adolescents, and young adults (under 24) during the first few months of therapy. Strict psychiatric monitoring is absolutely mandatory.
- The CYP1A2 & CYP2C19 Interaction (FATAL WARNING): Fluvoxamine is one of the most potent inhibitors of the CYP1A2 liver enzyme in all of pharmacology. It is strictly contraindicated with Tizanidine, Clozapine, Ramelteon, or Thioridazine. Combining Fluvoxamine with these drugs will cause a massive, potentially fatal 10x to 50x overdose of the co-administered medication.
- Serotonin Syndrome: Co-administration with MAOIs, SNRIs, Triptans, or Tramadol can trigger a fatal cascade of hyperthermia, rigid muscles, and autonomic instability.
- Severe Discontinuation Syndrome: Abruptly stopping Fluvoxamine causes violent withdrawal symptoms (brain zaps, severe nausea, electric shock sensations). The dose must be tapered over several weeks.
Global Export & Contract Manufacturing Services
Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Psychiatric Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antidepressants, Anxiolytics, and Content-Uniformity Assured Formulations. Whether you are looking for a reliable Government Tender Supplier for behavioral health clinics in Africa or a B2B Pharma Marketplace partner for the CIS, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.








Reviews
There are no reviews yet.